Story · Medicine & Biotech

Ankit Kansagra and Shebli Atrash Discuss Aspirin vs. DOACs in Multiple Myeloma

1 outlet · first reported by OncoDaily 3d ago

Coverage, in order

  1. 3d ago
    OncoDaily obscure
    Ankit Kansagra and Shebli Atrash Discuss Aspirin vs. DOACs in Multiple Myeloma

    Ankit Kansagra, Medical Oncologist and Associate Vice President of Oncology Integration, shared Shebli Atrash’s, Oncologist at Levine Cancer Institute, post on X, adding: “Aspirin or a DOAC at lenalidomide (len)

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.